Softlab9 Technologies Inc. announced that it has signed a distribution agreement with HEG, S. de C.V. (HEG) to distribute personal protective equipment (PPE) across the USA and Canada. In an LOI signed on August 25, 2020, Softlab9 secured 100% exclusive rights to distribute Level II, Level III and Level IV isolation gowns and coveralls, as well as surgical masks in Canada. The products are manufactured in Mexico at HEG's factory. As part of Softlab9's due diligence, On August 21st, 2020 the company received 100 of each of the Level II and Level III coveralls and gowns to be used for testing and approval from Health Canada and/or the US Food and Drug Administration (FDA). The surgical masks are the standard 3-ply or 4-ply disposable masks and do not require regulatory testing approval. Softlab9 will now begin the process of contacting Health Canada as well as regulatory bodies in the USA to get the various gowns tested and approved for sale in North America. Softlab9 will secure a spot in the queue with the regulatory bodies. The company will update once a spot has been secured. Once Softlab9 receives the approvals from both jurisdictions, it will have met the requirements to secure exclusivity in distributing the personal protective equipment in Canada. A profit-sharing agreement will be structured, whereas profits will be split equally (50/50) between Softlab9 and HEG. The company expects to have a definitive agreement executed by September 30, 2020, along with sending all the necessary garments for regulatory testing and approval for sale in Canada and the USA.